Tempo Therapeutics is Other Pharmaceuticals and Biotechnology in United States that focus on control inflammation business. Founded in 2013. They cover business area such as developer, an injectable hydrogel, regenerative tissue treatment, cell-free synthetic material, geometric technology, control inflammation, patient, reduce chronic tissue inflammation, regenerative healing.
Other Pharmaceuticals and Biotechnology
2013
( 11 years old in 2024 )
Control Inflammation
-
3030 Bunker Hill Street
Suite 104
San Diego, CA 92109
United States
Private
developeran injectable hydrogelregenerative tissue treatmentcell-free synthetic materialgeometric technologycontrol inflammationpatientreduce chronic tissue inflammationregenerative healing
* We use standard office opening hours in near Tempo Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Tempo Therapeutics is Other Pharmaceuticals and Biotechnology business from United States that founded in 2013 (11 years old in 2024), Tempo Therapeutics business is focusing on Control Inflammation.
Tempo Therapeutics headquarter office and corporate office address is located in 3030 Bunker Hill Street Suite 104 San Diego, CA 92109 United States.
Tempo Therapeutics was founded in United States.
In 2024, Tempo Therapeutics is currently focus on control inflammation sector.
Above is snippet of Google Trends for "control inflammation" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Tempo Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
